artemisinin has been researched along with Age-Related Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Qiao, P; Wu, S; Yao, G; Zhang, J; Zhang, L; Zhao, H | 1 |
| Chen, Y; Cheng, Y; Li, P; Liu, H; Lu, X; Ma, Y; Song, C; Wang, Y; Zhang, Z | 1 |
2 other study(ies) available for artemisinin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Artesunate inhibits osteoclast differentiation by inducing ferroptosis and prevents iron overload-induced bone loss.
Topics: Artemisinins; Artesunate; Cell Differentiation; Ferroptosis; Humans; Iron; Iron Overload; Osteoclasts; Osteoporosis | 2023 |
Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Topics: Artemether; Artemisinins; Artesunate; Caspase 3; Drugs, Chinese Herbal; ErbB Receptors; Humans; Interleukin-17; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Osteoporosis; Prolactin | 2022 |